Healthcare Triangle PE Ratio 2020-2025 | HCTI

Current and historical p/e ratio for Healthcare Triangle (HCTI) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Healthcare Triangle PE ratio as of August 12, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Healthcare Triangle PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-08-12 3.04 0.00
2025-03-31 74.60 $-0.90 0.00
2024-12-31 245.61 $-1.15 0.00
2024-09-30 122.01 $-2.18 0.00
2024-06-30 128.38 $-2.42 0.00
2024-03-31 463.14 $-2.56 0.00
2023-12-31 683.51 $-2.94 0.00
2023-09-30 948.69 $-2.98 0.00
2023-06-30 580.17 $-3.22 0.00
2023-03-31 999.74 $-2.90 0.00
2022-12-31 447.45 $-2.70 0.00
2022-09-30 923.79 $-2.60 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.018B $0.012B
Healthcare Triangle Inc. is a healthcare information technology company focused on solutions in the areas of cloud services, data science, professional and managed services for the healthcare and life sciences industry. Healthcare Triangle Inc. is based in PLEASANTON, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.009B 57.26
Doximity (DOCS) United States $11.611B 51.52
Tempus AI (TEM) United States $11.485B 0.00
Hims & Hers Health (HIMS) United States $10.735B 88.82
IRhythm Technologies (IRTC) United States $5.216B 0.00
Hinge Health (HNGE) United States $4.368B 0.00
Privia Health (PRVA) United States $2.542B 188.27
Inspire Medical Systems (INSP) United States $2.482B 36.49
Phreesia (PHR) United States $1.657B 0.00
Enovis (ENOV) United States $1.643B 8.69
10x Genomics (TXG) United States $1.577B 0.00
Omnicell (OMCL) United States $1.449B 27.91
Schrodinger (SDGR) United States $1.383B 0.00
Azenta (AZTA) United States $1.339B 58.42
Clover Health Investments (CLOV) United States $1.272B 0.00
Claritev (CTEV) United States $1.080B 0.00
Evolent Health (EVH) United States $1.033B 0.00
Fulgent Genetics (FLGT) United States $0.643B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Standard BioTools (LAB) United States $0.498B 0.00
Zepp Health (ZEPP) Netherlands $0.496B 0.00
Talkspace (TALK) United States $0.419B 125.00
Carlsmed (CARL) $0.351B 0.00
Butterfly Network (BFLY) United States $0.350B 0.00
TruBridge (TBRG) United States $0.294B 51.53
Nyxoah SA (NYXH) Belgium $0.228B 0.00
Outset Medical (OM) United States $0.225B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.212B 0.00
Health Catalyst (HCAT) United States $0.211B 0.00
KORU Medical Systems (KRMD) United States $0.192B 0.00
CapsoVision (CV) United States $0.188B 0.00
MDxHealth SA (MDXH) Belgium $0.136B 0.00
American Well (AMWL) United States $0.110B 0.00
CareCloud (CCLD) United States $0.107B 4.87
EUDA Health Holdings (EUDA) Singapore $0.096B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.093B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
Pulmonx (LUNG) United States $0.065B 0.00
111 (YI) China $0.058B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
HeartBeam (BEAT) United States $0.041B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00